<DOC>
	<DOCNO>NCT00041353</DOCNO>
	<brief_summary>RATIONALE : Examining biomarkers fine-needle aspiration specimen woman risk breast cancer may improve ability detect breast cancer cell early plan effective treatment . PURPOSE : Screening trial compare specific biomarkers base fine-needle aspiration specimen woman increase normal risk breast cancer .</brief_summary>
	<brief_title>Comparison Biomarkers Based Fine-Needle Aspiration Women Increased Normal Risk Breast Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Compare specific biomarkers , include cellular morphology ( cytology ) , proliferation index ( Ki-67 ) , p53 expression , LOH chromosome 9p locus DS9157 , fine needle aspirate specimen woman increase v normal risk breast cancer . - Determine whether specimen adequate perform biomarker assay whether technique could use general outpatient setting . - Determine whether biomarker level patient concordant discordant individual clinical risk breast cancer . - Determine whether 1 biomarkers distinguish high-risk control patient . - Correlate specific biomarkers change biomarker level pathologic diagnosis breast biopsy . OUTLINE : Patients undergo fine needle aspiration normal appear breast tissue prior begin elective surgery . Specimens analyze presence specific biomarkers . PROJECTED ACCRUAL : Approximately 156 patient accrue study within 3 year .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Increased risk breast cancer determine 1 firstdegree relative ( mother , sister , daughter ) history breast cancer OR personal history atypical hyperplasia , lobular carcinoma situ , ductal carcinoma situ breast OR No increase risk breast cancer determine lack condition Scheduled undergo elective breast surgery removal mammographic lesion palpable breast lump No prior bilateral mastectomy bilateral breast irradiation Hormone receptor status : Not specify PATIENT CHARACTERISTICS : Age : 30 Sex : Female Menopausal status : Not specify Performance status : Not specify Life expectancy : Not specify Hematopoietic : Not specify Hepatic : Not specify Renal : Not specify Other : No active invasive malignancy site except basal cell squamous cell skin cancer No significant medical psychiatric problem would preclude study No evidence excessive use narcotic drug dependency PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : Not specify Endocrine therapy : Not specify Radiotherapy : See Disease Characteristics Surgery : See Disease Characteristics</criteria>
	<gender>Female</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>ductal breast carcinoma situ</keyword>
	<keyword>lobular breast carcinoma situ</keyword>
</DOC>